Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Mesothelioma Cancer treatment details. Biologic therapy. University of Chicago, Chicago, IL, United States

Survival: 4.4 months
Toxicity Grade: 4
Treatments: Biologic therapy
Country: United States
City/State/Province: Chicago, IL
Hospital: University of Chicago
Journal: Link
Date: 10/2012

This phase II study involved 51 patients with malignant mesothelioma. The median patient age was 64 years and 84% were male.

Patients were treated with the biologic therapy agent cediranib, which is a tyrosine kinase inhibitor of VEGF receptors and interferes with maintaining the blood supply to tumors.

The most severe toxicities were of grade 4 and included fatigue and blood clotting. Grade 3 diarrhea was also reported.

The median overall survival was 4.4 months.

One of the authors has acted as a paid consultant for AstraZeneca, makers of cediranib.

Correspondence: Dr. Hedy L. Kindler; email:

E-mail to a Friend Email Physician More Information